Your session is about to expire
← Back to Search
High volume combined aerobic/resistance exercise for Diabetes (DEAL Trial)
Phase < 1
Waitlist Available
Led By Ron Sigal, MD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
DEAL Trial Summary
The objective of this study is to determine the effects of supervised combined aerobic and resistance training, and the effects of stage-matched written materials delivered by mail or internet, alone or in combination, on glycemic control as reflected in A1C (glycated hemoglobin).
DEAL Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The will be A1c at the end of 6 months supervised exercise period.
DEAL Trial Design
6Treatment groups
Active Control
Placebo Group
Group I: High volume combined aerobic/resistance exerciseActive Control1 Intervention
Group II: Low volume combined aerobic/resistance exerciseActive Control1 Intervention
Low volume combined aerobic/resistance exercise
Group III: High volume combined A/R exercise, printouts, pedometersActive Control1 Intervention
High volume combined aerobic/resistance exercise, printouts, pedometers
Group IV: Low volume combined A/R exercise, printouts, pedometersActive Control1 Intervention
Low volume combined aerobic/resistance exercise, printouts, pedometers
Group V: Printed PA information, pedometers and step log groupActive Control1 Intervention
Printed physical activity information, pedometers and step log group
Group VI: ControlPlacebo Group1 Intervention
Find a Location
Who is running the clinical trial?
University of CalgaryLead Sponsor
792 Previous Clinical Trials
869,128 Total Patients Enrolled
3 Trials studying Diabetes
395 Patients Enrolled for Diabetes
Ron Sigal, MDPrincipal InvestigatorUniversity of Calgary
1 Previous Clinical Trials
131 Total Patients Enrolled
1 Trials studying Diabetes
131 Patients Enrolled for Diabetes
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger